Blue Trust’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Blue Trust's WST Position: Q3 2026 in Review
Blue Trust reduced its West Pharmaceutical (WST) stake by 93% in Q3 2026, selling an estimated $89.3K and leaving 20 shares worth $7.42K. The position accounts for ﹤0.01% of the portfolio, ranked #1770.
Blue Trust first reported a position in WST in Q2 2022 and has held it in 18 quarters since. The position peaked at $270K in Q3 2024. 750 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Blue Trust held 20 shares of West Pharmaceutical worth $7.42K as of Q3 2026.
- Blue Trust sold 253 West Pharmaceutical shares in Q3 2026, an estimated $89.3K.
- West Pharmaceutical made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1770 holding.
- Blue Trust first reported a position in West Pharmaceutical in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's West Pharmaceutical position peaked at $270K in Q3 2024.
- 750 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.